The goal of this project is to identify three proteins of the intrinsic retinal visual cycle that maintain the sensitivity of cones under daylight conditions. During the previous funding period, the PI found that co- expression of RGR opsin and retinol dehydrogenase-10 (Rdh10) confers upon cells the capacity to take up all-trans-retinol (atROL) from the medium and release 11-cis-retinol (11cROL), only on exposure to visible light. The same atROL to 11cROL conversion activity has been observed by Mller cells, although not previously reported as light dependent. Cones, but not rods, possess an 11cROL- dehydrogenase (11cRDH) activity that allows them to utilize the 11cROL released by Mller cells to make 11cRAL chromophore and thereby regenerate photobleached cone opsins. The long-term goal of this project is to understand the processes that enable continuous cone vision during daylight exposure in mammals. Given the importance of cones to human vision, addressing this deficit in our knowledge is certainly within the NEI mission.
Specific Aim 1 is to determine the roles of RGR opsin and Rdh10 in the intrinsic retinal visual cycle. This will be accomplished in a collaborative study using biochemical and physiological methodologies. The central hypothesis for Aim 1 is that RGR opsin and Rdh10 comprise the 11cROL-generator in Mller cells, and that formation of 11cROL by these proteins is driven by light.
Specific Aim 2 is to identify the 11cRDH that allows cones to regenerate visual pigment from 11cROL. This will be accomplished using a cDNA expression-screen to test members of the short-chain dehydrogenase/reductase (SDR) family that are expressed in cones. The expected outcome of this study is the identification of three proteins that together comprise the intrinsic retinal visual cycle. These results amount to the uncovering of a new metabolic pathway in the retina. They will greatly extend our knowledge about the regeneration of cone visual pigment in daylight. Also, they will open the door to further genetic and functional biochemical studies into the retinal visual cycle, including the potential to identify new susceptibility loci for inherited retinopathies and maculopathies. Mutations in the human RGR gene have already been associated with retinitis pigmentosa in a small subset of cases. While it has been long appreciated that invertebrates, such as insects, use light to regenerate their visual pigments, this has never been shown for vertebrates. The PI's finding that light drives regeneration of cone visual pigment is therefore a novel and important discovery.

Public Health Relevance

The proposed research will provide important new information about the functioning of cones under daylight conditions. Preliminary studies suggest that the regeneration of cone pigments is driven by light through a novel biochemical mechanism in Mller cells. Given the importance of cones to human vision, the proposed research is highly relevant to the NEI mission. The gene for one of the proteins to be studied (RGR) is a susceptibility locus for retinitis pigmentosa, hence the project is also relevant to the broad NIH mission that pertains to reducing illness and disability.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY024379-04A1
Application #
9888120
Study Section
Biology of the Visual System Study Section (BVS)
Program Officer
Neuhold, Lisa
Project Start
2015-09-01
Project End
2024-12-31
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Cook, Jeremy D; Ng, Sze Yin; Lloyd, Marcia et al. (2017) Peropsin modulates transit of vitamin A from retina to retinal pigment epithelium. J Biol Chem 292:21407-21416
Kaylor, Joanna J; Xu, Tongzhou; Ingram, Norianne T et al. (2017) Blue light regenerates functional visual pigments in mammals through a retinyl-phospholipid intermediate. Nat Commun 8:16